Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Current Leases (2019 - 2022)

Aytu Biopharma (AYTU) has disclosed Current Leases for 4 consecutive years, with $1.2 million as the latest value for Q1 2022.

  • Quarterly Current Leases changed N/A to $1.2 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Mar 2022, changed N/A year-over-year, with the annual reading at $940000.0 for FY2021, 213.33% up from the prior year.
  • Current Leases for Q1 2022 was $1.2 million at Aytu Biopharma, up from $1.2 million in the prior quarter.
  • The five-year high for Current Leases was $1.2 million in Q1 2022, with the low at $79362.0 in Q3 2019.
  • Average Current Leases over 4 years is $534907.6, with a median of $294619.0 recorded in 2020.
  • The sharpest move saw Current Leases grew 21.16% in 2020, then skyrocketed 1069.92% in 2021.
  • Over 4 years, Current Leases stood at $82755.0 in 2019, then increased by 21.16% to $100263.0 in 2020, then surged by 1069.92% to $1.2 million in 2021, then increased by 2.56% to $1.2 million in 2022.
  • According to Business Quant data, Current Leases over the past three periods came in at $1.2 million, $1.2 million, and $1.1 million for Q1 2022, Q4 2021, and Q3 2021 respectively.